The Scan My Wife Didn't Get
Midjourney Medical's full-body ultrasound idea is not just a technology story. For families living with inherited cancer risk, it points at a different kind of NHS screening.
In November 2018, my wife died from bowel cancer.
She was 38.
She had Lynch syndrome, diagnosed when she was 21. For anyone who has not lived around it, Lynch syndrome is an inherited condition that raises the risk of bowel cancer and several other cancers. It meant surveillance became part of her life far too young.
Colonoscopies. Appointments. Results. Waiting.
A strange calendar for someone who should have been thinking about ordinary things.
She had a colonoscopy every two years.
Thirteen months before she died, she had been checked.
During that check, they took a biopsy from the area because there was colitis. The result came back as inflammation.
Thirteen months later, she was gone. A massive tumour in her large intestine.
I have replayed that fact in my head more times than I can count. Not because I think one doctor, one appointment, or one test can be neatly blamed. Medicine is not that simple. Bodies are not that simple. Cancer certainly is not that simple.
But I still come back to the same question.
What if she had also had a scan?
What if there had been a way to see not just the inside surface of the bowel, but what was happening around it? What if the tumour was already growing outward, beyond what a colonoscopy was best placed to detect? What if the technology had existed to make that kind of check routine, cheap, fast and safe enough to do often?
That is why the Midjourney Medical announcement stopped me.
The claim
Midjourney says it is working on something it calls “Ultrasonic CT”, or full-body ultrasound.
The claim is extraordinary: whole-body imaging in as little as 60 seconds, with no ionising radiation and no powerful magnetic fields. Just sound, water and a minute of time.
It sounds almost too good to believe.
And maybe it is, at least in the short term. Medical devices are not software demos. They need evidence. Trials. Regulation. Clinical workflows. Trained people. Safety checks. Proof that they improve outcomes rather than just create thousands of ambiguous findings that frighten people and overload doctors.
But if even part of this vision becomes real, it matters.
It matters because the NHS is always making trade-offs.
Screening is a capacity problem
A CT scan is not nothing. It uses X-rays. Doctors rightly weigh the benefit against the risk, especially when someone may need repeated scans over many years. For younger women, pregnancy and fertility considerations can sit in that risk calculation too.
The caution is understandable. Nobody wants unnecessary radiation. Nobody wants medicine to become reckless because grief and fear are driving the decision.
But the other side of caution is that some people are not looked at closely enough, often enough.
And some of those people die.
That is the part we do not talk about cleanly, because it is uncomfortable. Every screening programme is a compromise. Every interval between checks is a bet. Every decision not to scan is shaped by population risk, machine capacity, cost, radiation exposure and clinical judgement.
Most of the time, those decisions will be reasonable.
But if you are the unlucky one, reasonable does not comfort you.
My wife was not careless. She was not ignoring symptoms for years. She knew she was high risk. The system knew she was high risk. She was being monitored.
And still, somehow, the cancer got ahead.
The promise is abundance
That is why projects like Midjourney Medical matter to me.
Not because they replace doctors. Not because they magically solve cancer. Not because every person should be scanned constantly and every shadow chased until the NHS collapses under incidental findings.
The promise is different.
The promise is that screening might one day become abundant.
Not scarce. Not rationed by machine time, radiation exposure, cost, and the availability of specialists. Not reserved for when symptoms have already become worrying enough.
Abundant.
Imagine an NHS where people with Lynch syndrome could have broader, more frequent imaging without the same radiation concern. Imagine hereditary cancer clinics where surveillance was not only a colonoscopy every couple of years, but a fuller picture of what is changing inside the body.
Imagine catching a tumour not when it has become obvious, but when it is still small enough to change the ending.
That is the future I want to believe in.
The tool is not enough
Technology alone will not fix the NHS.
The NHS needs staff, funding, capacity, better data, better pathways and less political vandalism. A scanner, however clever, does not help if nobody can interpret the results, explain them, follow them up, reassure patients, prioritise dangerous findings and avoid drowning people in false alarms.
This is the part that usually gets lost in technology announcements.
The hard bit is rarely the machine on its own. It is the structure around it.
Who gets scanned?
How often?
Who reads the result?
What happens when the scan finds something uncertain?
How do you avoid creating panic for thousands of people while still catching the one tumour that matters?
How does the result get back into the patient’s record, the genetics clinic, the colorectal team, the GP, and the next surveillance decision?
That is the real work.
But better tools change what structures are possible.
MRI changed what was possible. CT changed what was possible. Colonoscopy changed what was possible. Blood tests, genetics and pathology changed what was possible.
If a safe, fast, low-cost, radiation-free imaging system becomes real, then cancer surveillance could change again.
The calendar high-risk families live by
For families with Lynch syndrome, BRCA mutations and other inherited risks, that could be enormous.
These families live with a different kind of calendar. They do not just have birthdays, school terms and holidays. They have screening intervals. They have “next colonoscopy due”. They have the quiet anxiety before results. They have the knowledge that normal today does not guarantee normal tomorrow.
My hope is that future generations do not have to live with quite so much guesswork.
My hope is that a young woman diagnosed with Lynch syndrome at 21 does not spend the rest of her life relying on checks that are good, but incomplete.
My hope is that we build systems where doctors can look more often, more safely and more completely.
My hope is that the next person like my wife gets the scan she did not.
I am not writing this because I think one technology company has solved cancer.
I am writing it because I know what it feels like when surveillance fails.
And if there is even a chance that new imaging technology can help the NHS catch more cancers earlier, especially for high-risk patients, then we should be paying very close attention.
Not with hype.
With urgency.
Because behind every screening policy is a family hoping the system sees the danger in time.
Mine did not.
Maybe one day, someone else’s will.
Jonathan Gill is founder of Squared Lemons, helping UK businesses adopt AI without the corporate waffle.